By ETF Desk
Manipal Health, a leading Indian diagnostic platform, has earned the nod from the Securities and Exchange Board of India (SEBI) to float an initial public offering (IPO) valued at ₹8,000 crore.
The approval follows a comprehensive review of the company’s financials, governance practices, and market strategy. With a network of over 400 labs across Karnataka, the firm now aims to raise capital to expand its digital healthcare initiatives, enhance laboratory infrastructure, and strengthen its foothold in the burgeoning healthtech market.
The IPO is expected to attract significant retail and institutional investors, especially those keen on the health sector’s growth trajectory. For Udupi residents and the broader Karnataka region, the move could signify increased access to advanced diagnostics and potential job creation in allied services. Source: Google News – Manipal.